31. March 2015

Probiodrug reports full year 2014 financial results

20. March 2015

Probiodrug to present data on its Anti-pGlu-3 Abeta monoclonal Antibody at the 12th International Conference on Alzheimer's and Parkinson's Diseases (AD/PDTM 2015), Nice 

9. March 2015

Probiodrug announces enrolment of first patient in Phase 2 Study of novel Treatment for Alzheimer's disease

3. March 2015

Data on Glutaminyl Cyclases (QCs) in its relation to Alzheimer's Disease (AD) published in Acta Neuropathologica

25. February 2015

Probiodrug to present at European Life Sciences Conferences

16. February 2015

Roche übernimmt Signature Diagnostics zur Verstärkung der translationalen Forschung für Diagnostika basierend auf Sequenzierungsmethoden der nächsten Generation (NGS)

9. February 2015

Probiodrug to Present at Drug Discovery USA 2015

4. February 2015

Probiodrug to present at 17th Annual BIO CEO & Investor Conference, New York City